These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 15919432)
1. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529 [TBL] [Abstract][Full Text] [Related]
3. [Liver transplantation for primary biliary cirrhosis: retrospective analysis of results at a single center]. Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P Dtsch Med Wochenschr; 2006 Oct; 131(42):2327-32. PubMed ID: 17043982 [TBL] [Abstract][Full Text] [Related]
5. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040 [TBL] [Abstract][Full Text] [Related]
6. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [TBL] [Abstract][Full Text] [Related]
7. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Levitsky J; Hart J; Cohen SM; Te HS Liver Transpl; 2003 Jul; 9(7):733-6. PubMed ID: 12827561 [TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762 [TBL] [Abstract][Full Text] [Related]
9. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091 [TBL] [Abstract][Full Text] [Related]
10. [Liver transplantation for primary biliary cirrhosis: retrospective analysis of 52 patients in QLTS]. Xu CE; Lynch SV; Balderson GA; Fawcett J; Strong RW; Yeong S Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):543-5. PubMed ID: 15387907 [TBL] [Abstract][Full Text] [Related]
11. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436 [TBL] [Abstract][Full Text] [Related]
12. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847 [TBL] [Abstract][Full Text] [Related]
13. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center. Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753 [TBL] [Abstract][Full Text] [Related]
14. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235 [No Abstract] [Full Text] [Related]
15. Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal. Campsen J; Zimmerman M; Trotter J; Wachs M; Bak T; Steinberg T; Kaplan M; Kam I Transplant Proc; 2009 Jun; 41(5):1707-12. PubMed ID: 19545712 [TBL] [Abstract][Full Text] [Related]
16. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401 [TBL] [Abstract][Full Text] [Related]
17. Conversion of cyclosporine A to tacrolimus following heart transplantation. Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of immunosuppression withdrawal after liver transplantation. Girlanda R; Rela M; Williams R; O'Grady JG; Heaton ND Transplant Proc; 2005 May; 37(4):1708-9. PubMed ID: 15919439 [TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study. Khettry U; Anand N; Faul PN; Lewis WD; Pomfret EA; Pomposelli J; Jenkins RL; Gordon FD Liver Transpl; 2003 Jan; 9(1):87-96. PubMed ID: 12514778 [TBL] [Abstract][Full Text] [Related]
20. Clinical use of FK 506 in liver transplantation. Klintmalm GB Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]